2 months Legend Biotech Co. (NASDAQ:LEGN) Receives Consensus Recommendation of “Buy” from Analysts MarketBeat
Shares of Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) have been given an average recommendation of “Buy” by the fourteen brokerages that are currently covering the stock, MarketBeat Ratings reports. Fourteen equities research analysts have rate…
Biotech · Nasdaq 100 · Science
X